CERT / Certara, Inc.'s (CERT) CEO William Feehery on Q1 2022 Results - Earnings Call Transcript

Certara, Inc. provides biosimulation software and services to the biotech and biopharma industry. The company is enjoying sales growth from its softwa more_horizontal

Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday after the biotech software company missed Wall Street's adjusted earnin more_horizontal

Certara Inc. (NASDAQ:CERT ) Q2 2023 Results Conference Call August 9, 2023 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO a more_horizontal

PRINCETON, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company manage more_horizontal

Certara, Inc. (NASDAQ:CERT ) Q1 2023 Results Conference Call May 8, 2023 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO Joh more_horizontal

Certara, Inc. (CERT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. more_horizontal

Certara, Inc. (CERT) delivered earnings and revenue surprises of 14.29% and 4.34%, respectively, for the quarter ended December 2022. Do the numbers h more_horizontal

Unlike Schrodinger, Certara posted a profit in the last quarter. Business momentum is accelerating as backlog grows. more_horizontal